USA Weight Management Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Revenue Breakdown (Based On New Subscribers, Recurring Subscribers), By Firm Size (Large (Greater Than 1 Million Subscribers), Small (Less Than 1 Million Subscribers)), And By Age (Less Than 50, More Than 50) - Forecasts From 2023 To 2028

People in the United States have a difficult time maintaining a healthy weight. Obesity is a well-known concern in the country, and the prevalence of this illness is increasing. This chronic disease of body fat accumulation puts one's health at risk for various medical problems. Behavioral modifications that aid in the development of long-term healthy habits are crucial. A healthy weight is attained and maintained by a combination of good food, physical activity, appropriate sleep, and stress management. Several other factors may also influence weight gain. Market expansion can be attributed to the rapid acceptance of online weight loss and management programs, increases in disposable income levels, increased government actions to raise awareness about weight management, and increase in obesity cases due to sedentary lifestyles.

Growth factors:

Obesity-related disorders are becoming an increasing concern in the US

Obesity is a chronic condition that affects more than one in every three people and around 17% of children and adolescents in the United States, according to the US Department of Health and Human Services. Being overweight affects one out of every three adults. Obesity prevalence in the United States grew from 30.5% to 41.9% between 1999 and 2020, based on the results of the National Health and Nutrition Examination Survey (NHANES). Simultaneously, the prevalence of extreme obesity rose from 4.7% to 9.2%. Obesity and being overweight increase your chances of developing type 2 diabetes, heart disease, stroke, fatty liver disease, kidney disease, and other health issues. As a result, the Biden-Harris Administration announced more than US$8 billion in additional pledges as part of the White House Conference on Hunger, Nutrition, and Health Call to Action in September 2022. To lower the prevalence of obesity, more than $4 billion will be allocated to philanthropy that enhances access to nutritious food, encourages healthy choices, and increases physical exercise. These efforts will eventually broaden the weight management market in the United States.

FDA clearance for the use of weight-management drugs

When compared to an inactive treatment that does not utilize medicine, called a placebo, the prescription weight loss results in significant weight loss. The combination of weight loss medicine and lifestyle changes results in greater weight loss than lifestyle changes alone. Weight-loss medicines are not quick fixes for weight management. However, they may assist in making the necessary lifestyle modifications to practice decreasing weight and improving health. For instance, in June 2021 in addition to a lower calorie diet and more exercise, Wegovy injectable was approved by the US Food and Drug Administration for the management of chronic weight in people who are obese or overweight and have at least one weight-related disorder. Additionally, Eli Lilly and Company said in October 2022 that the FDA has given tirzepatide's research for the treatment of adults with obesity or overweight who also have weight-related comorbidities Fast Track status. For people who are obese or overweight, Lilly intends to start a rolling submission of a new drug application (NDA) for tirzepatide. It is anticipated that acceptance of these medications will fuel market expansion.

AI integration in the weight management area

Artificial intelligence has permeated practically every area and industry on the planet, and its presence in weight control is notable. Weight management organizations are now focused on the ability of AI to create simple-to-adapt weight-control procedures. As technology advances, these AI-powered programs become more popular among the general public. For instance, Signos aims to combat the obesity problem in the United States by providing a new way for people to act on their body's unique response to what and when they consume to lose weight and start living a healthy life. In November 2021, Signos came out with stealth mode and highlighted its mission to assist people to make data-driven decisions that will improve their daily lives and create a healthier population. This is made possible by continuous glucose monitoring and then the use of AI to interpret a person's metabolic data into pertinent dietary and activity suggestions. Dexcom, the biggest supplier of glucose monitoring devices for managing diabetes, is collaborating with Signos as well. As its first investment in the field of health, wellness, and weight management, Dexcom has also made a strategic investment in the business.

Key Developments:

• January 2023: Ro, the premier direct-to-patient healthcare company, has announced the launch of the Ro Body Program, a comprehensive weight loss program that includes access to GLP-1 drugs, the most powerful prescription obesity therapies today. Ro promises to help millions of Americans suffering from obesity reach their weight loss objectives by providing access to prescription therapy backed up by individualized physician care, diagnostic testing with at-home sample collection, and 1:1 counseling from nurses.
• January 2022: A reputable supplier of clinically validated weight-loss programs, HMR (Health Management Resources), from Merck was acquired by Providence St. Joseph Health. The newest example of Providence's non-profit healthcare organization's efforts to enhance the health and well-being of patients and communities is the addition of a complete weight management program to its menu of medical services.

USA Weight Management Market Scope:

Segmentation:

• By revenue breakdown
  • Based on New Subscribers
  • Recurring Subscribers
• By firm size
  • Large (Greater than 1 million subscribers)
  • Small (Less than 1 million subscribers)
• By age
  • Less than 50
  • More than 50